The portfolio Abbott brings to Australia and New Zealand reflects the specific health priorities of both nations. Trusted nutritional brands including Ensure, Glucerna, PediaSure and EleCare support people at every stage of life, from childhood through to the management of serious conditions like cancer-related nutritional decline, diabetes and kidney disease. Abbott is a world leader in rapid point-of-care and infectious disease testing, and its technologies support the screening of 100 percent of blood donors across Australia and New Zealand — ensuring the safety of the blood supply for everyone who depends on it. In heart health, Abbott provides innovative stents, pacemakers and structural heart devices including MitraClip for the management of mitral valve regurgitation, representing some of the most significant recent progress in cardiac care.